‘Like looking for a needle in a haystack’: the global hunt to find key molecule to block COVID-19

Artificial intelligence identifying compounds
18-May-2020 6:05 AM EDT, by University of South Australia

Newswise — A molecular biologist from the University of South Australia is working with a world leader in artificial intelligence-based drug discovery to help find a molecule that could prevent the SARS-CoV-2 coronavirus strain causing COVID-19 from infecting human cells.

Dr Gokhan Cildir has been selected by San Francisco company Atomwise to collaborate on research to use artificial intelligence to discover compounds that could successfully fight SARS-CoV-2. 

From millions of molecules screened virtually, Atomwise has identified likely contenders and has sent those compounds to Dr Cildir to test at the Centre for Cancer Biology (CCB) in Adelaide. The goal is to develop inhibitors for the ‘spike’ protein used by SARS-CoV-2 to invade human cells.

“Although coronavirus uses many different proteins to replicate and invade cells, the spike protein is the major cell surface protein that it uses to bind to a host receptor — another protein that acts like a doorway into a human cell,” Dr Cildir says.

“I believe there is a very high chance we will get a vaccine in the next year, but our own approach is to find the compound which can actually block SARS-CoV-2 because it will be impossible to vaccinate everyone in the world, especially the most vulnerable.”

The team hopes over the next 6-12 months to identify compounds which could potentially be patented and tested in vitro and animal models before undertaking any clinical trials in humans.

Atomwise is leveraging its unique AI-based drug discovery model for several other projects in the fight against COVID-19. There are currently 15 efforts underway and the company anticipates that number will grow.

“Atomwise’s patented AI technology has been proven in hundreds of prospective projects to discover drug leads for a wide variety of diseases, and we’re very optimistic about the role we can play when it comes to COVID-19,” says Dr Stacie Calad-Thomson, vice president and head of Artificial Intelligence Molecular Screen (AIMS) Partnerships at Atomwise.

“We’re hopeful that the therapies discovered will not only target this pandemic, but potential future recurrences.”

Dr Cildir, who is funded by The Hospital Research Foundation, is a postdoctoral researcher based in CCB’s Allergy and Cancer Immunology Laboratory led by Dr Damon Tumes. He has been working at UniSA since late 2016 after completing his PhD at the National University of Singapore in the School of Medicine.

He has previously collaborated with Atomwise on other work, but this is his first virology project.

“It is like looking for a needle in a haystack but if we are successful it will be a world first, so we are very excited about the possibilities,” he says.




Filters close

Showing results

1120 of 2584
Released: 15-Jul-2020 5:35 PM EDT
Researchers Identify Genetic Factors that May Influence COVID-19 Susceptibility
Cleveland Clinic

A new Cleveland Clinic study has identified genetic factors that may influence susceptibility to COVID-19. Published today in BMC Medicine, the study findings could guide personalized treatment for COVID-19.

Released: 15-Jul-2020 4:30 PM EDT
COVID-19 Travel Patterns in New Jersey
Rutgers University-New Brunswick

At the height of the coronavirus shutdown in the spring, travel to more than 150,000 points of interest throughout New Jersey, including retail, health care, food stores and other essential and non-essential establishments decreased up to 80 percent compared to the first week of March when the state was still opened, according to a Rutgers report.

Newswise: ShortTermDistancing.jpg
Released: 15-Jul-2020 4:10 PM EDT
Social distancing and COVID-19: A law of diminishing returns
Washington University in St. Louis

Modeling from the McKelvey School of Engineering at Washington University in St. Louis shows how social distancing could have better been implemented. The key? Longer periods of distancing would have helped — but only to a point. More needed to be done.

Newswise: About nine family members to suffer grief from every COVID-19 fatality
Released: 15-Jul-2020 3:05 PM EDT
About nine family members to suffer grief from every COVID-19 fatality
Penn State Institute for Computational and Data Sciences

Deaths from COVID-19 will have a ripple effect causing impacts on the mental health and health of surviving family members. But the extent of that impact has been hard to assess until now. Every death from COVID-19 will impact approximately nine surviving family members, according to a study.

Released: 15-Jul-2020 2:45 PM EDT
People with Coronavirus Symptoms More Likely to Have General Psychiatric Disorders and Loneliness
University of Cambridge

People who have or had COVID-19 symptoms are more likely to develop general psychiatric disorders and are lonelier, with women and young people more at risk, says a just-published study co-authored at Cambridge Judge Business School.

Released: 15-Jul-2020 1:10 PM EDT
In one hour, surface coating inactivates virus that causes COVID-19
Virginia Tech

A Virginia Tech chemical engineering professor has developed a surface coating that, when painted on common objects, inactivates SARS-CoV-2, the virus that causes COVID-19.

Released: 15-Jul-2020 1:05 PM EDT
After universal masking, health care worker COVID-19 rates drop at Mass General Brigham
Brigham and Women’s Hospital

In March of 2020, Mass General Brigham implemented a new policy: everyone working at the hospitals would be required to wear a surgical mask.

Newswise: 237522_web.jpg
Released: 15-Jul-2020 12:40 PM EDT
Global sentiments towards COVID-19 shifts from fear to anger
Nanyang Technological University

The fear that people developed at the start of the COVID-19 outbreak has given way to anger over the course of the pandemic, a study of global sentiments led by Nanyang Technological University, Singapore (NTU Singapore) has found.


Showing results

1120 of 2584

close
1.64132